๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Antibody-directed therapy of multidrug-resistant tumor cells

โœ Scribed by Thomas Efferth; Manfred Volm

Book ID
112963961
Publisher
Springer US
Year
1992
Tongue
English
Weight
793 KB
Volume
9
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Bispecific antibodies reactive with the
Bispecific antibodies reactive with the multidrug-resistance-related glycoprotein and CD3 induce lysis of multidrug-resistant tumor cells
โœ J. van Dijk; T. Tsuruo; D. M. Segal; R. L. H. Bolhuis; R. Colognola; R. J. van d ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 620 KB

## We describe the lysis of multidrug-resistant (MDR) tumor cells by various lymphocytic effector cells, retargeted with bispecific antibodies (heteroconjugates). The Ab -heteroconjugate used was prepared by chemically cross-linking the OKT3 monoclonal antibody (MAb) reactive with CD3 antigen on T

Targeting multidrug resistant tumor cell
Targeting multidrug resistant tumor cells with a recombinant single-chain FV fragment directed to P-glycoprotein
โœ Revital Niv; Yehuda G. Assaraf; Dina Segal; Esther Pirak; Yoram Reiter ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 264 KB

The MDR1 gene product P-glycoprotein (Pgp) plays a key role in multidrug resistance of cancer cells. Pgp is an ATPdriven efflux pump that extrudes a variety of dissimilar hydrophobic cytotoxic compounds. P-glycoprotein overexpression results in multidrug resistance (MDR) of tumor cell lines in vitro